uturn

Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk’s Wegovy oral weight-loss drug.

July 15, 2025 (Investorideas.com Newswire) Investorideas.com, a go-to platform for big investing ideas, including AI and tech issues market commentary from deVere Group. The Nasdaq is on the…